INVESTERINGSANPARTSSELSKABET 'FREMTIDEN'. SLAGELSE

 

Quicksearch
Company Name




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.4% 5.8% 5.7% 6.0% 5.2%  
Credit score (0-100)  37 39 39 38 43  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  81.1 101 89.2 97.1 86.7  
EBITDA  81.1 101 89.2 97.1 86.7  
EBIT  56.0 76.1 64.1 83.0 72.6  
Pre-tax profit (PTP)  46.8 67.3 53.9 72.3 62.8  
Net earnings  36.4 52.3 42.0 58.5 48.3  
Pre-tax profit without non-rec. items  46.8 67.3 53.9 72.3 62.8  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  955 930 905 594 580  
Shareholders equity total  386 438 480 242 290  
Interest-bearing liabilities  578 552 527 501 476  
Balance sheet total (assets)  1,072 1,094 1,116 845 858  

Net Debt  569 552 391 419 198  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  81.1 101 89.2 97.1 86.7  
Gross profit growth  -23.4% 24.8% -11.9% 8.9% -10.7%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,072 1,094 1,116 845 858  
Balance sheet change%  -1.5% 2.0% 2.0% -24.3% 1.6%  
Added value  81.1 101.2 89.2 108.1 86.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -50 -50 -50 -102 -260  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  69.1% 75.2% 71.9% 85.5% 83.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  5.2% 7.0% 5.8% 8.5% 8.5%  
ROI %  5.7% 7.7% 6.4% 9.4% 9.6%  
ROE %  9.9% 12.7% 9.1% 16.2% 18.2%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  36.0% 40.1% 43.0% 28.6% 33.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  702.4% 545.4% 438.2% 431.5% 228.2%  
Gearing %  149.8% 126.0% 109.7% 207.3% 163.9%  
Net interest  0 0 0 0 0  
Financing costs %  1.6% 1.6% 1.9% 2.1% 2.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.0 1.4 1.7 2.0 2.4  
Current Ratio  1.0 1.4 1.7 2.0 2.4  
Cash and cash equivalent  9.0 0.4 136.1 82.4 278.0  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1.9 47.2 84.8 126.5 160.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0